An intranasal vaccine to aid in prevention of feline infectious peritonitis (FIP) caused by FIP virus.
FELOCELL FIP is for intranasal (IN) vaccination of healthy cats 16 weeks of age or older as an aid in preventing feline infectious peritonitis (FIP) caused by feline infectious peritonitis virus (FIPV). FELOCELL FIP contains an attenuated, temperature-sensitive (TS) strain of FIP virus propagated on an established feline cell line. The vaccine is freeze-dried to preserve stability.
Cats vaccinated intranasally (IN) with FELOCELL FIP develop a protective immune response and do not become hypersensitized. This practical benefit may be attributed to the temperature-sensitive FELOCELL FIP vaccine strain, which replicates in the upper respiratory tract but does not spread systemically at 39°C, the cat’s body temperature.
1. General Directions: Vaccination of healthy cats is recommended. Aseptically rehydrate the freeze-dried vaccine with the sterile diluent provided. Mix well. Use dropper to inoculate entire volume into nasal passages (1/2 volume into each nasal passage). Cats may sneeze or shake their heads at the time of administration.
2. Primary Vaccination: Healthy cats 16 weeks of age or older should receive 2 IN doses administered 3-4 weeks apart.
3. Revaccination: Annual revaccination with a single dose is recommended.
PRECAUTIONS: Store at 2°-7°C. Prolonged exposure to higher temperatures and/or direct sunlight may adversely affect potency. Do not freeze.
Use entire contents when first opened.
Burn containers and all unused contents.
Droppers should be used to administer this vaccine.
As with many vaccines, anaphylaxis may occur after use. Initial antidote of epinephrine is recommended and should be followed with appropriate supportive therapy.
This product has been shown to be efficacious in healthy animals. A protective immune response may not be elicited if animals are incubating an infectious disease, are malnourished or parasitized, are stressed due to shipment or environmental conditions, are otherwise immunocompromised, or the vaccine is not administered in accordance with label directions.
Technical inquiries should be directed to Zoetis Veterinary Services, (800) 366-5288 (USA), (800) 461-0917 (Canada).